Making cancer treatment side effects better


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9


Enlivity offers affordable, nutrient-based products which address painful side effects of cancer treatment that occur in the mouth and GI tract.

Our first product is Healios, an oncologist-developed, over-the-counter, glutamine-based formula that helps the cells lining the mouth and throat stay healthy during chemotherapy and radiation treatment. 


When cancer patients begin treatment, their bodies become battlefields.

While treatments aggressively combat the disease, they also wreak havoc, often causing painful, potentially dangerous side effects. 

Every year, half a million Americans in treatment suffer from oral mucositis -- painful, debilitating mouth sores which can last several weeks. These sores make swallowing extremely painful, preventing patients from eating or drinking and increasing the likelihood of:


We believe cancer patients should enjoy full, active lives while they’re still in treatment.

But side effects like oral mucositis make it impossible for patients to live comfortably, stay social, continue activities, or even be at home with the people they love.

We’re offering safe, science-backed products that alleviate pain, reduce costs, and help patients persevere. Introducing Enlivity.


Enlivity develops science-backed, nutrient-based products that alleviate side effects of cancer treatment occurring in the mouth and digestive tract.

We currently offer Healios: an over-the-counter dietary supplement that supports the health of cells in the mouth, throat and esophagus.


Our formula contains glutamine, a naturally occurring amino acid that helps damaged cells heal.

Unlike other glutamine products, Healios’ formula is designed for targeted relief, increasing glutamine absorption directly at the mucosal lining that protects the mouth, throat, and esophagus.


No need for prescriptions and long waits-- patients can order Healios on our website and have a package shipped to their address. Once it arrives, Healios is easy to take:


Healios has passed all regulatory hurdles, is patented, and has already been used by 2000+ patients nationwide -- many of whom are repeat customers.



We’re ready to meet patient needs. Our manufacturing and inventory is secured,
our fulfillment and distribution is in place.

We have several partners on board, helping to keep operations running smoothly:



GILLIAN ISABELLE, PHD | Founder and Chief Executive Officer

  • Former Head of Business Development, Broad Institute of MIT and Harvard
  • Venture creation at PureTech Health
  • R&D and business development at Corning, Inc.
  • PhD from MIT; Materials Science and Engineering 

JILL TOBACCO, MPH RD | Co-Founder and Chief Marketing Officer

  • Former Director, Marketing and Communications, DentaQuest & Delta Dental of MA
  • Consumer Product and Healthcare Marketing at Global Agencies
  • Clinical Dietitian at Hospitals and the California Department of Public Health
  • MPH, UC Berkeley; Community Health & Nutrition


SHAWNA VOGEL, MBA | Chief Operating Officer

  • Former Director of Grant and Contract Administration, MIT
  • Former Executive Director, Center for Regenerative Medicine, MGH
  • Operations, Strategy and Alliances management
  • MBA, Babson College

Gillian left the biotech industry to start a company that doesn’t see patients as statistics -- instead focusing on their humanity, their experiences, their relationships, and their enjoyment of life.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.